These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 17636947)
1. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators. Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947 [TBL] [Abstract][Full Text] [Related]
2. Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones. Higuchi RI; Arienti KL; López FJ; Mani NS; Mais DE; Caferro TR; Long YO; Jones TK; Edwards JP; Zhi L; Schrader WT; Negro-Vilar A; Marschke KB J Med Chem; 2007 May; 50(10):2486-96. PubMed ID: 17439112 [TBL] [Abstract][Full Text] [Related]
3. Selective androgen receptor modulators based on a series of 7H-[1,4]oxazino[3,2-g]quinolin-7-ones with improved in vivo activity. Long YO; Higuchi RI; Caferro TR; Lau TL; Wu M; Cummings ML; Martinborough EA; Marschke KB; Chang WY; López FJ; Karanewsky DS; Zhi L Bioorg Med Chem Lett; 2008 May; 18(9):2967-71. PubMed ID: 18400499 [TBL] [Abstract][Full Text] [Related]
4. Discovery of potent and muscle selective androgen receptor modulators through scaffold modifications. Li JJ; Sutton JC; Nirschl A; Zou Y; Wang H; Sun C; Pi Z; Johnson R; Krystek SR; Seethala R; Golla R; Sleph PG; Beehler BC; Grover GJ; Fura A; Vyas VP; Li CY; Gougoutas JZ; Galella MA; Zahler R; Ostrowski J; Hamann LG J Med Chem; 2007 Jun; 50(13):3015-25. PubMed ID: 17552509 [TBL] [Abstract][Full Text] [Related]
5. Serendipitous discovery of novel imidazolopyrazole scaffold as selective androgen receptor modulators. Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2007 Jan; 17(2):439-43. PubMed ID: 17079140 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of potent and tissue-selective androgen receptor modulators (SARMs): 2-(2,2,2)-Trifluoroethyl-benzimidazole scaffold. Ng RA; Lanter JC; Alford VC; Allan GF; Sbriscia T; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2007 Mar; 17(6):1784-7. PubMed ID: 17197181 [TBL] [Abstract][Full Text] [Related]
8. Identification of a 4-(hydroxymethyl)diarylhydantoin as a selective androgen receptor modulator. Nique F; Hebbe S; Triballeau N; Peixoto C; Lefrançois JM; Jary H; Alvey L; Manioc M; Housseman C; Klaassen H; Van Beeck K; Guédin D; Namour F; Minet D; Van der Aar E; Feyen J; Fletcher S; Blanqué R; Robin-Jagerschmidt C; Deprez P J Med Chem; 2012 Oct; 55(19):8236-47. PubMed ID: 22957947 [TBL] [Abstract][Full Text] [Related]
9. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators. Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661 [TBL] [Abstract][Full Text] [Related]
10. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones. van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219 [TBL] [Abstract][Full Text] [Related]
11. 2-(2,2,2-Trifluoroethyl)-5,6-dichlorobenzimidazole derivatives as potent androgen receptor antagonists. Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2007 Feb; 17(4):955-8. PubMed ID: 17134895 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of potent and selective androgen receptor antagonists: 5,6-Dichloro-benzimidazole derivatives. Ng RA; Guan J; Alford VC; Lanter JC; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z Bioorg Med Chem Lett; 2007 Feb; 17(3):784-8. PubMed ID: 17095226 [TBL] [Abstract][Full Text] [Related]
13. Discovery of diarylhydantoins as new selective androgen receptor modulators. Nique F; Hebbe S; Peixoto C; Annoot D; Lefrançois JM; Duval E; Michoux L; Triballeau N; Lemoullec JM; Mollat P; Thauvin M; Prangé T; Minet D; Clément-Lacroix P; Robin-Jagerschmidt C; Fleury D; Guédin D; Deprez P J Med Chem; 2012 Oct; 55(19):8225-35. PubMed ID: 22897611 [TBL] [Abstract][Full Text] [Related]
14. Selective androgen receptor modulators: in pursuit of tissue-selective androgens. Omwancha J; Brown TR Curr Opin Investig Drugs; 2006 Oct; 7(10):873-81. PubMed ID: 17086931 [TBL] [Abstract][Full Text] [Related]
15. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist. Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines. Hamann LG; Higuchi RI; Zhi L; Edwards JP; Wang XN; Marschke KB; Kong JW; Farmer LJ; Jones TK J Med Chem; 1998 Feb; 41(4):623-39. PubMed ID: 9484511 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators. Manfredi MC; Bi Y; Nirschl AA; Sutton JC; Seethala R; Golla R; Beehler BC; Sleph PG; Grover GJ; Ostrowski J; Hamann LG Bioorg Med Chem Lett; 2007 Aug; 17(16):4487-90. PubMed ID: 17574413 [TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation. Jones A; Hwang DJ; Duke CB; He Y; Siddam A; Miller DD; Dalton JT J Pharmacol Exp Ther; 2010 Aug; 334(2):439-48. PubMed ID: 20444881 [TBL] [Abstract][Full Text] [Related]
19. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators. Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807 [TBL] [Abstract][Full Text] [Related]
20. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties. Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]